PFCS
CMPX icon

Pale Fire Capital SE’s Compass Therapeutics CMPX Stock Holding History

Pale Fire Capital SE’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-30,507
Closed -$56.1K – 55
2024
Q3 		$56.1K Sell
30,507
-52,270
-63% -$65.1K 0.01% 47
2024
Q2 		$82.8K Sell
82,777
-43,191
-34% -$63.1K 0.01% 40
2024
Q1 		$249K Sell
125,968
-55,087
-30% -$95.2K 0.03% 31
2023
Q4 		$282K Buy
181,055
+135,900
+301% +$235K 0.04% 45
2023
Q3 		$89K Buy
+45,155
New +$112K 0.01% 57

Other funds holding CMPX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Pale Fire Capital SE's CMPX Position: Q4 2024 in Review

Pale Fire Capital SE sold out of Compass Therapeutics (CMPX) in Q4 2024, closing a stake of 30,507 shares — an estimated $56.1K sold.

Pale Fire Capital SE first reported a position in CMPX in Q3 2023 and held it in 5 quarters. The position peaked at $282K in Q4 2023. 92 funds tracked by Wall St. Rank hold CMPX as of Q4 2024.

  • Pale Fire Capital SE reported no remaining Compass Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Pale Fire Capital SE sold 30,507 Compass Therapeutics shares in Q4 2024, an estimated $56.1K.
  • Pale Fire Capital SE first reported a position in Compass Therapeutics in Q3 2023 and held it in 5 quarters.
  • Pale Fire Capital SE's Compass Therapeutics position peaked at $282K in Q4 2023.
  • 92 funds tracked by Wall St. Rank held Compass Therapeutics as of Q4 2024.

Based on Pale Fire Capital SE's 13F filing for Q4 2024, filed 13 Feb 2025.